Axitinib

Required

Axitinib is primarily employed in the treatment of advanced renal cell carcinoma (kidney cancer). Acting as a tyrosine kinase inhibitor, Axitinib impedes the growth of cancer cells by thwarting the blood vessels' formation that nourishes the tumors.